New Treatments & Clinical Trials for Anxiety

Anxiety disorders affect about 1 in 5 adults and include generalized anxiety, social anxiety, panic disorder, and phobias. Current treatment combines therapy (especially cognitive behavioral therapy) with medications like SSRIs, SNRIs, and benzodiazepines. Many people respond well, but side effects, slow onset, and incomplete relief drive interest in new approaches.

What's actually going on in research

Trials are testing fast-acting drugs that work through different brain pathways than SSRIs, digital therapeutics that deliver therapy through apps, psychedelic-assisted therapy for treatment-resistant cases, and drugs that target specific anxiety circuits. Researchers are also studying biomarkers that might predict which treatment will work for whom.

What to know before you search

Eligibility typically depends on anxiety severity scores, specific diagnosis type, whether you've tried standard treatments, and absence of certain other mental health conditions.

What types of trials are currently open

• Medication trials — Testing new pills or nasal sprays against placebo or existing medications, usually over 8-12 weeks. Most measure anxiety symptoms weekly using standard questionnaires.
• Digital therapy trials — Testing apps that deliver cognitive behavioral therapy, mindfulness training, or exposure exercises. May be used alone or alongside medication.
• Psychedelic trials — Small studies testing MDMA or psilocybin in controlled settings with trained therapists, typically 2-3 dosing sessions over several weeks.
• Neurostimulation trials — Testing devices that stimulate the brain or vagus nerve to reduce anxiety, either through implants or external devices.
• Observational studies — Following people with anxiety to understand what predicts treatment response, how symptoms change over time, and what factors trigger worsening.